Market Overview

UPDATE: Wunderlich Reiterates Hold Rating, Raises PT on HeartWare International

Related HTWR
Keep An Eye On This New Activist Hedge Fund Managed By Former JPMorgan Executives
HeartWare Terminates Proposed Acquisition of Valtech Cardio

In a report published Wednesday, Wunderlich Securities reiterated its Hold rating on HeartWare International (NASDAQ: HTWR), and raised its price target from $80.00 to $96.00.

Wunderlich noted, “Heartware (HTWR) announced very strong Q2 results after the close Tuesday. Revenues of $29.1mm increased 42% and were well above our high-end estimate of $25.3mm and Street consensus of $22.8mm. The loss of ($1.61) per share was much larger than our estimate of ($1.40), as R&D spending took another step up. Strong International performance (+76%) once again this quarter was exciting, as HTWR increasingly dominated the market outside the U.S. On the HVAD approval front, management remains hopeful of a near-term approval, but really offered no new insight into the process. We continue to assume a late 2012 approval. We reiterate our Hold rating, but are raising our price target on Heartware to $96 per share.”

HeartWare International closed on Tuesday at $86.88.

Latest Ratings for HTWR

Jan 2016Raymond JamesUpgradesMarket PerformOutperform
Jan 2016
Oct 2015Piper JaffrayDowngradesOverweightNeutral

View More Analyst Ratings for HTWR
View the Latest Analyst Ratings

Posted-In: Wunderlich SecuritiesAnalyst Color Price Target Analyst Ratings


Related Articles (HTWR)

View Comments and Join the Discussion!

Get Benzinga's Newsletters